Indication: This product is suitable for the following moderate and severe infections caused by sensitive bacteria: respiratory system infections: acute bronchitis, acute exacerbation of chronic bronchitis, diffuse bacterial bronchitis, bronchiectasis and infection, pneumonia, tonsillitis (peritonsillar abscess); urinary system infections: pyelonephritis, complicated urinary tract infection, etc.; reproductive system infections: acute prostatitis, acute epididymitis, uterine cavity infection, uterine adnexitis, pelvic inflammatory disease (metronidazole can be used in combination when anaerobic infection is suspected); skin and soft tissue infections: infectious impetigo, cellulitis, lymphangiitis (adenitis), subcutaneous abscess, perianal abscess, etc.; intestinal infections: bacillary dysentery, infectious enteritis, salmonella enteritis, typhoid and paratyphoid; various infections in patients with sepsis, neutropenia and immunodeficiency; other infections: mastitis, trauma, burns and postoperative wound infection, abdominal infection (metronidazole can be used in combination when necessary), cholecystitis, cholangitis, bone and joint infection and ENT infection, etc.

Indication: This product is suitable for the following moderate and severe infections caused by sensitive bacteria: respiratory system infections: acute bronchitis, acute exacerbation of chronic bronchitis, diffuse bacterial bronchitis, bronchiectasis and infection, pneumonia, tonsillitis (peritonsillar abscess); urinary system infections: pyelonephritis, complicated urinary tract infection, etc.; reproductive system infections: acute prostatitis, acute epididymitis, uterine cavity infection, uterine adnexitis, pelvic inflammatory disease (metronidazole can be used in combination when anaerobic infection is suspected); skin and soft tissue infections: infectious impetigo, cellulitis, lymphangiitis (adenitis), subcutaneous abscess, perianal abscess, etc.; intestinal infections: bacillary dysentery, infectious enteritis, salmonella enteritis, typhoid and paratyphoid; various infections in patients with sepsis, neutropenia and immunodeficiency; other infections: mastitis, trauma, burns and postoperative wound infection, abdominal infection (metronidazole can be used in combination when necessary), cholecystitis, cholangitis, bone and joint infection and ENT infection, etc.

Indication: This product is suitable for the following moderate and severe infections caused by sensitive bacteria: respiratory system infections: acute bronchitis, acute exacerbation of chronic bronchitis, diffuse bacterial bronchitis, bronchiectasis and infection, pneumonia, tonsillitis (peritonsillar abscess); urinary system infections: pyelonephritis, complicated urinary tract infection, etc.; reproductive system infections: acute prostatitis, acute epididymitis, uterine cavity infection, uterine adnexitis, pelvic inflammatory disease (metronidazole can be used in combination when anaerobic infection is suspected); skin and soft tissue infections: infectious impetigo, cellulitis, lymphangiitis (adenitis), subcutaneous abscess, perianal abscess, etc.; intestinal infections: bacillary dysentery, infectious enteritis, salmonella enteritis, typhoid and paratyphoid; various infections in patients with sepsis, neutropenia and immunodeficiency; other infections: mastitis, trauma, burns and postoperative wound infection, abdominal infection (metronidazole can be used in combination when necessary), cholecystitis, cholangitis, bone and joint infection and ENT infection, etc.

Indication: To reduce the emergence of drug-resistant bacteria and ensure the effectiveness of levofloxacin mesylate and other antimicrobial drugs, levofloxacin is only used to treat or prevent infections that have been proven or highly suspected to be caused by sensitive bacteria. The results of bacterial culture and drug sensitivity tests should be considered when selecting or modifying antimicrobial treatment regimens. If there are no data from these tests for reference, empirical treatment should be carried out based on local epidemiology and pathogen sensitivity. Before treatment, bacterial culture and drug sensitivity tests should be performed to isolate and identify the infecting pathogens and determine their sensitivity to levofloxacin mesylate. Levofloxacin can be used for treatment before the above test results are obtained, and appropriate treatment methods can be selected after the test results are obtained. Like other drugs in this class, some strains of Pseudomonas aeruginosa can quickly develop drug resistance when levofloxacin mesylate is used for treatment. Bacterial culture and drug sensitivity tests should be performed regularly during treatment to understand whether the pathogens are continuously sensitive to antimicrobial drugs and to detect drug resistance in a timely manner after the bacteria develop resistance. Levofloxacin mesylate oral preparations and injections can be used to treat the following mild, moderate and severe infections caused by sensitive strains of the following bacteria in adults (≥18 years old). Levofloxacin mesylate injection can be used when intravenous drip is more beneficial to the patient (such as the patient cannot tolerate oral administration, etc.). 1. Hospital-acquired pneumonia is used to treat hospital-acquired pneumonia caused by methicillin-sensitive Staphylococcus aureus, Pseudomonas aeruginosa, Serratia marcescens, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae or Streptococcus pneumoniae. At the same time, other auxiliary treatment measures should be taken according to clinical needs. If Pseudomonas aeruginosa infection has been proven or suspected, it is recommended to combine anti-pseudomonal β-lactam drugs for treatment. 2. 7-14-day treatment regimen for community-acquired pneumonia: Treatment of community-acquired pneumonia caused by methicillin-sensitive Staphylococcus aureus, Streptococcus pneumoniae [including multidrug-resistant strains (MDRSP*)], Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Chlamydia pneumoniae, Legionella pneumococcus, or Mycoplasma pneumoniae. Note: MDRSP (multidrug-resistant Streptococcus pneumoniae) refers to strains resistant to two or more of the following antimicrobial drugs: penicillin (MIC ≥ 2µg/mL), second-generation cephalosporins (such as cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. 5-day treatment regimen: Treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Mycoplasma pneumoniae, or Chlamydia pneumoniae. 3. 5-day treatment regimen for acute bacterial sinusitis: Treatment of acute bacterial sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. 10-14 days treatment plan: Treatment of acute bacterial sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. 4. Acute bacterial exacerbations of chronic bronchitis Treatment of acute bacterial exacerbations of chronic bronchitis caused by methicillin-susceptible Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, or Moraxella catarrhalis. 5. Complicated skin and skin structure infections Treatment of complicated skin and skin structure infections caused by methicillin-susceptible Staphylococcus aureus, Enterococcus faecalis, Streptococcus pyogenes, or Proteus mirabilis. 6. Uncomplicated skin and skin and soft tissue infections Treatment of uncomplicated skin and skin structure infections (mild to moderate) caused by methicillin-susceptible Staphylococcus aureus or Streptococcus pyogenes, including abscesses, cellulitis, furuncle, impetigo, pyoderma, and wound infections. 7. Chronic bacterial prostatitis Treatment of chronic bacterial prostatitis caused by Escherichia coli, Enterococcus faecalis, or methicillin-sensitive Staphylococcus epidermidis. 8. 5-day treatment regimen for complicated urinary tract infection: Treatment of complicated urinary tract infection caused by Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis. 10-day treatment regimen: Treatment of complicated urinary tract infection (mild to moderate) caused by Enterococcus faecalis, Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, or Pseudomonas aeruginosa. 9. 5-day treatment regimen for acute pyelonephritis: Treatment of acute pyelonephritis caused by Escherichia coli, including names with bacteremia. 10-day treatment regimen: Treatment of acute pyelonephritis caused by Escherichia coli, including names with bacteremia. 10. Uncomplicated urinary tract infection: Treatment of uncomplicated urinary tract infection (mild to moderate) caused by Escherichia coli, Klebsiella pneumoniae, or Staphylococcus saprophyticus. 11. Inhalation anthrax (post-exposure) is indicated for the treatment of inhalation anthrax (post-exposure), to reduce the occurrence of the disease or slow the progression of the disease after exposure to anthrax spray. The effectiveness of levofloxacin is based on the human plasma concentration as a surrogate endpoint to predict clinical efficacy. The preventive effect of levofloxacin after anthrax inhalation exposure has not been tested in humans. The safety of levofloxacin for treatment of more than 28 days in adults has not been studied. Levofloxacin can only be used for long-term treatment when the benefits outweigh the risks.

Indication: This product is suitable for the following moderate and severe infections caused by sensitive bacteria: respiratory system infections: acute bronchitis, acute exacerbation of chronic bronchitis, diffuse bacterial bronchitis, bronchiectasis and infection, pneumonia, tonsillitis (peritonsillar abscess); urinary system infections: pyelonephritis, complicated urinary tract infection, etc.; reproductive system infections: acute prostatitis, acute epididymitis, uterine cavity infection, uterine adnexitis, pelvic inflammatory disease (metronidazole can be used in combination when anaerobic infection is suspected); skin and soft tissue infections: infectious impetigo, cellulitis, lymphangiitis (adenitis), subcutaneous abscess, perianal abscess, etc.; intestinal infections: bacillary dysentery, infectious enteritis, salmonella enteritis, typhoid and paratyphoid; various infections in patients with sepsis, neutropenia and immunodeficiency; other infections: mastitis, trauma, burns and postoperative wound infection, abdominal infection (metronidazole can be used in combination when necessary), cholecystitis, cholangitis, bone and joint infection and ENT infection, etc.

Indication: It is mainly used for various infections caused by sensitive Gram-positive and Gram-negative bacteria and Pseudomonas aeruginosa infections, including sepsis, meningitis, endocarditis, purulent pleurisy, peritonitis and infections of the lower respiratory tract, gastrointestinal tract, bile duct, urinary tract, bone and soft tissue and reproductive organs, gynecological and obstetric infections, malignant otitis externa, burns, skin and surgical infections, etc.

Indication: It is mainly used for various infections caused by sensitive Gram-positive and Gram-negative bacteria and Pseudomonas aeruginosa infections, including sepsis, meningitis, endocarditis, purulent pleurisy, peritonitis and infections of the lower respiratory tract, gastrointestinal tract, bile duct, urinary tract, bone and soft tissue and reproductive organs, gynecological and obstetric infections, malignant otitis externa, burns, skin and surgical infections, etc.

Indication: It is mainly used for various infections caused by sensitive Gram-positive and Gram-negative bacteria and Pseudomonas aeruginosa infections, including sepsis, meningitis, endocarditis, purulent pleurisy, peritonitis and infections of the lower respiratory tract, gastrointestinal tract, bile duct, urinary tract, bone and soft tissue and reproductive organs, gynecological and obstetric infections, malignant otitis externa, burns, skin and surgical infections, etc.

Indication: It is mainly used for various infections caused by sensitive Gram-positive and Gram-negative bacteria and Pseudomonas aeruginosa infections, including sepsis, meningitis, endocarditis, purulent pleurisy, peritonitis and infections of the lower respiratory tract, gastrointestinal tract, bile duct, urinary tract, bone and soft tissue and reproductive organs, gynecological and obstetric infections, malignant otitis externa, burns, skin and surgical infections, etc.

Indication: It is mainly used for various infections caused by sensitive Gram-positive and Gram-negative bacteria and Pseudomonas aeruginosa infections, including sepsis, meningitis, endocarditis, purulent pleurisy, peritonitis and infections of the lower respiratory tract, gastrointestinal tract, bile duct, urinary tract, bone and soft tissue and reproductive organs, gynecological and obstetric infections, malignant otitis externa, burns, skin and surgical infections, etc.